{"gene":"CHRNA3","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1998,"finding":"The CHRNA3 gene (encoding the neuronal nicotinic acetylcholine receptor α3 subunit) was structurally characterized: its genomic organization was determined and it was mapped to the chromosome 15q24 gene cluster together with CHRNB4 and CHRNA5, providing the structural basis for mutational analyses.","method":"Genomic cloning and structural characterization","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct structural/genomic characterization; single lab, single method","pmids":["9921897"],"is_preprint":false},{"year":2001,"finding":"Mice lacking the α3 subunit (CHRNA3 ortholog) show severe autonomic phenotypes including megacystis, failure of bladder strips to contract in response to nicotine, widely dilated ocular pupils, growth failure, and perinatal mortality, establishing CHRNA3 as essential for nicotinic fast synaptic transmission in autonomic ganglia.","method":"Knockout mouse model with pharmacological and functional assays (bladder contraction assay)","journal":"Journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular/organ phenotype including in vitro pharmacological assay; consistent with human disease data","pmids":["11450844"],"is_preprint":false},{"year":2000,"finding":"Refined genetic mapping placed the CHRNA3/A5/B4 cluster in a 0.6 cM interval between STRs D15S1027 and D15S1005 on chromosome 15q24, and segregation analysis excluded this cluster from the ADNFLE-linked 15q24 region.","method":"Genetic mapping via segregation analysis of polymorphisms in ADNFLE families","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 2 — direct genetic mapping with family segregation data; single lab","pmids":["10923651"],"is_preprint":false},{"year":2011,"finding":"In vitro luciferase reporter assays showed that CHRNA3 promoter haplotypes produced equivalent luciferase expression in BE(2)-C neuronal cells, while CHRNA5 promoter variants altered expression; allelic expression imbalance (AEI) analysis in post-mortem brain tissue heterozygous at CHRNA3 rs1051730 showed mostly equivalent allelic expression, suggesting CHRNA3 promoter haplotypes do not strongly drive differential mRNA output.","method":"Luciferase reporter assay (in vitro), allelic expression imbalance analysis in post-mortem brain tissue","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro functional assay plus ex vivo tissue analysis; single lab with two orthogonal methods","pmids":["21858091"],"is_preprint":false},{"year":2013,"finding":"In vitro luciferase assays showed that the CHRNA3/B4 intergenic SNPs rs8023462 and rs6495309 influence gene expression in an allele-specific, cell-type-dependent manner; EMSA demonstrated that nuclear proteins bind rs8023462 and rs6495309 alleles differentially, and GATA transcription factors bind rs8023462 only when the minor/risk allele is present.","method":"Luciferase reporter assay, electrophoretic mobility shift assay (EMSA), transcription factor binding analysis","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with multiple orthogonal methods (luciferase + EMSA + specific TF identification)","pmids":["23872218"],"is_preprint":false},{"year":2016,"finding":"Integration of GTEx RNA expression data showed that the CHRNA5 enhancer haplotype tagged by rs880395 increases CHRNA3 mRNA expression (in addition to CHRNA5), suggesting DNA looping from a shared enhancer to multiple promoters; in nucleus accumbens and putamen specifically, CHRNA3 expression associates with a distinct haplotype tagged by rs1948 in the CHRNB4 3'UTR, indicating brain-region-specific regulatory mechanisms.","method":"eQTL analysis using GTEx data, chromatin looping inference, linkage disequilibrium analysis","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 — regulatory inference from large-scale RNA data without direct chromatin confirmation; but multiple datasets used","pmids":["27758088"],"is_preprint":false},{"year":2021,"finding":"Loss-of-function variants in CHRNA3 (compound heterozygous frameshift c.907_908delCT/missense p.D230N, or homozygous frameshift) cause familial autonomic ganglionopathy with diffuse panautonomic failure (severe neurogenic orthostatic hypotension, non-reactive miotic pupils, constipation, low norepinephrine), establishing CHRNA3 as essential for fast ganglionic synaptic transmission in the human autonomic nervous system. Structural modeling predicted the p.D230N variant destabilizes the nAChR pentameric complex at the subunit interface.","method":"Whole exome sequencing, genetic co-segregation, structural modeling (PolyPhen2/SIFT/protein modeling)","journal":"Neurology","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function variants with defined human disease phenotype replicated across two unrelated families; structural modeling provides mechanistic support","pmids":["33947782"],"is_preprint":false},{"year":2024,"finding":"Novel compound heterozygous CHRNA3 variants were identified in a patient with neurogenic bladder, vesicoureteral reflux, mydriasis, and gastrointestinal dysmotility, extending the phenotypic spectrum of CHRNA3 loss of function to include CAKUT features consistent with disrupted autonomic ganglionic neurotransmission.","method":"Clinical genetic sequencing, phenotypic characterization","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 3 — single case report with genetic variants; mechanistic inference based on known CHRNA3 function","pmids":["38192228"],"is_preprint":false},{"year":2025,"finding":"In zebrafish, chrna3 knockout blunted the biphasic (attraction-to-aversion) alcohol self-administration response and increased alcohol tolerance; transcriptomic analysis of mutant brains showed changes in glutamatergic, GABAergic, and cholinergic signaling, establishing that chrna3 modulates alcohol response through its role in cholinergic signaling in the CNS.","method":"Zebrafish chrna3 knockout, two-choice self-administration behavioral assay, transcriptomic analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined behavioral phenotype plus transcriptomic mechanism; single lab, ortholog model","pmids":["40992927"],"is_preprint":false},{"year":2025,"finding":"Chromosome conformation capture (3C) identified that rs2036527 lies in an enhancer region that physically interacts with the CHRNA3 promoter (and also CHRNA5 promoter); luciferase assay confirmed rs2036527 alters enhancer activity; ChIP identified FOXA2 as a transcription factor that interacts with the rs2036527-containing enhancer. Allele-specific expression showed the C allele at rs1051730 (in strong LD with rs2036527) is overexpressed in lung tissue, establishing rs2036527 as the functional cis-regulatory variant for CHRNA3 expression.","method":"3C (chromosome conformation capture), luciferase assay, ChIP, allele-specific expression analysis, eQTL analysis","journal":"The American journal on addictions","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (3C + luciferase + ChIP + allele-specific expression) in single study identifying functional regulatory variant and transcription factor","pmids":["40755048"],"is_preprint":false},{"year":2012,"finding":"Luciferase assays in lung-cancer-derived cell lines showed that nicotine and other tobacco chemicals have diverse effects on luciferase activity driven by the CHRNA3 promoter rs6495309C or T alleles, indicating that the rs6495309T>C polymorphism in the CHRNA3 promoter affects transcriptional activity in a ligand- and allele-dependent manner.","method":"Luciferase reporter assay with nicotine and tobacco chemical treatment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro functional assay demonstrating allele-dependent promoter activity; single lab, single method","pmids":["23056235"],"is_preprint":false},{"year":2025,"finding":"Transgenic zebrafish expressing fluorescent reporters under chrna3 regulatory sequences showed that chrna3 is expressed in both the peripheral and central nervous systems, including enteric nervous system, lateral line efferent inhibitory neurons, and spinal cord motor neurons and interneurons (including dmrt3a-expressing interneurons), establishing a basis for its role in the locomotor network and autonomic function.","method":"Transgenic reporter zebrafish, fluorescence imaging, co-expression analysis with cell-type markers","journal":"Developmental neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vivo localization with functional cell-type context; ortholog in zebrafish","pmids":["39686588"],"is_preprint":false},{"year":2010,"finding":"CHRNA3 rs1051730 polymorphism was associated with reduced prepulse inhibition (PPI) of the acoustic startle response in two independent samples (healthy volunteers and schizophrenia patients), indicating that CHRNA3 genetic variation influences sensorimotor gating, a function mediated by nicotinic acetylcholine receptor signaling.","method":"Human genetic association with electrophysiological endophenotype (PPI), replicated in two independent cohorts","journal":"Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 3 — genetic association with functional electrophysiological readout; replicated across two independent samples","pmids":["20393456"],"is_preprint":false},{"year":2013,"finding":"In healthy nonsmoking volunteers in a placebo-controlled crossover study, nicotine enhanced PPI only in CHRNA3 rs1051730 TT homozygotes and tended to worsen PPI in TC/CC carriers, demonstrating that CHRNA3 genotype modulates the pharmacological effect of nicotine on sensorimotor gating.","method":"Double-blind placebo-controlled crossover study with PPI measurement and CHRNA3 genotyping; cotinine plasma levels measured","journal":"Psychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — controlled pharmacological challenge with functional readout and genotype stratification; single lab","pmids":["23604333"],"is_preprint":false}],"current_model":"CHRNA3 encodes the α3 subunit of the neuronal nicotinic acetylcholine receptor (nAChR), which is essential for fast cholinergic synaptic transmission in autonomic ganglia (established by mouse knockout and human loss-of-function variants causing panautonomic failure); its expression is regulated by a cis-acting enhancer containing rs2036527 that is bound by FOXA2 and loops to the CHRNA3 (and CHRNA5) promoter, with allele-specific effects on transcription; intergenic SNPs (rs8023462, rs6495309) in the CHRNA3/B4 region also modulate gene expression through allele-specific nuclear protein binding including GATA transcription factors; CHRNA3 variation influences sensorimotor gating (PPI) through nicotinic receptor-mediated mechanisms, and its zebrafish ortholog regulates alcohol tolerance via cholinergic, glutamatergic, and GABAergic signaling in the brain."},"narrative":{"teleology":[{"year":1998,"claim":"Defining the genomic architecture of the CHRNA3/A5/B4 cluster on 15q24 provided the structural framework needed to pursue mutational and regulatory analyses of the α3 subunit gene.","evidence":"Genomic cloning and structural characterization of CHRNA3 gene organization and chromosomal mapping","pmids":["9921897"],"confidence":"Medium","gaps":["No functional data on receptor assembly or stoichiometry","Promoter regulatory elements not yet tested"]},{"year":2001,"claim":"Knockout of the mouse α3 subunit established that CHRNA3 is required for fast nicotinic synaptic transmission in autonomic ganglia, explaining the severe autonomic phenotype (megacystis, pupil dilation, perinatal death).","evidence":"Chrna3 knockout mice with bladder contraction pharmacological assays showing absent nicotine response","pmids":["11450844"],"confidence":"High","gaps":["Human disease causation not yet demonstrated","Contribution to CNS function not addressed","Whether other nAChR subunits can partially compensate in specific ganglia unknown"]},{"year":2010,"claim":"CHRNA3 rs1051730 was linked to reduced prepulse inhibition in two independent human cohorts, revealing a CNS function for CHRNA3 in sensorimotor gating beyond its autonomic role.","evidence":"Genetic association of rs1051730 with PPI of acoustic startle in healthy volunteers and schizophrenia patients","pmids":["20393456"],"confidence":"Medium","gaps":["Association does not prove causality at CHRNA3 vs linked variants","Neural circuit mediating the PPI effect not identified","No pharmacological confirmation yet"]},{"year":2011,"claim":"Promoter haplotype testing showed CHRNA3 promoter variants themselves do not strongly drive allelic expression imbalance in brain, redirecting attention to distal regulatory elements.","evidence":"Luciferase reporter assays in BE(2)-C cells and allelic expression imbalance analysis in post-mortem brain tissue","pmids":["21858091"],"confidence":"Medium","gaps":["Distal enhancer elements not yet tested","Tissue-specific regulation beyond brain not examined"]},{"year":2012,"claim":"The rs6495309 polymorphism in the CHRNA3 promoter region was shown to alter transcriptional activity in response to nicotine and tobacco chemicals in an allele-dependent manner, linking environmental exposure to genotype-specific gene regulation.","evidence":"Luciferase reporter assays with nicotine/tobacco chemical treatments in lung cancer cell lines","pmids":["23056235"],"confidence":"Medium","gaps":["In vivo relevance of ligand-dependent promoter modulation not confirmed","Transcription factors mediating the response not identified"]},{"year":2013,"claim":"Two advances refined CHRNA3 regulation and CNS pharmacology: intergenic SNPs rs8023462/rs6495309 were shown to recruit allele-specific nuclear proteins including GATA factors to regulate CHRNA3/B4 expression, and a pharmacological challenge study demonstrated that CHRNA3 genotype determines whether nicotine enhances or worsens sensorimotor gating.","evidence":"EMSA and luciferase assays identifying GATA binding at rs8023462; double-blind placebo-controlled nicotine crossover study with PPI and rs1051730 genotyping","pmids":["23872218","23604333"],"confidence":"Medium","gaps":["GATA factor identity not specified beyond family level","Whether PPI genotype effect is mediated by CHRNA3 expression level or receptor function unknown","ChIP confirmation of GATA binding at endogenous locus not performed"]},{"year":2016,"claim":"GTEx eQTL analysis revealed that a shared enhancer haplotype (tagged by rs880395) increases both CHRNA3 and CHRNA5 expression, while brain-region-specific regulation of CHRNA3 maps to a distinct CHRNB4 3'UTR haplotype, indicating multi-layered cis-regulatory control.","evidence":"eQTL analysis across GTEx tissues with linkage disequilibrium and chromatin looping inference","pmids":["27758088"],"confidence":"Medium","gaps":["Physical chromatin contact not directly demonstrated (inferred from eQTL data)","Mechanism of region-specific regulation not elucidated"]},{"year":2021,"claim":"Identification of biallelic CHRNA3 loss-of-function variants in two unrelated families with panautonomic failure proved that CHRNA3 is essential for human autonomic ganglionic transmission, translating the mouse knockout phenotype to a defined Mendelian disease.","evidence":"Whole exome sequencing, co-segregation in two families, structural modeling of p.D230N at pentameric subunit interface","pmids":["33947782"],"confidence":"High","gaps":["No electrophysiological recording from patient ganglia","Receptor assembly and trafficking effects of mutations not tested in vitro","Potential CNS manifestations not systematically assessed"]},{"year":2025,"claim":"Three studies broadened the functional portrait: zebrafish chrna3 knockout established a role in alcohol tolerance via cholinergic/glutamatergic/GABAergic signaling; transgenic reporters mapped chrna3 expression to enteric, lateral line, and spinal motor/interneuron populations; and chromosome conformation capture identified rs2036527 as a functional cis-regulatory variant in a FOXA2-bound enhancer that physically contacts the CHRNA3 promoter.","evidence":"Zebrafish KO with behavioral and transcriptomic analysis; transgenic fluorescent reporters with cell-type markers; 3C, ChIP, luciferase, and allele-specific expression in human lung tissue","pmids":["40992927","39686588","40755048"],"confidence":"High","gaps":["Whether FOXA2-enhancer mechanism operates in neuronal tissues beyond lung not tested","Circuit-level mechanism by which chrna3 loss alters alcohol response unknown","Human in vivo confirmation of enhancer-promoter loop pending"]},{"year":null,"claim":"Key unresolved questions include the structural basis for α3 subunit incorporation into specific pentameric receptor subtypes, the identity of CHRNA3-containing receptor complexes in different CNS circuits, and whether enhancer-mediated regulation by FOXA2 and GATA factors operates in autonomic ganglia where CHRNA3 function is most critical.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No cryo-EM or crystallographic structure of α3-containing pentamers","Subunit stoichiometry preferences (α3β4 vs α3β2 vs mixed) in native tissue not resolved","Tissue-specific enhancer activity in autonomic neurons not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,6,11]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,6,8,12,13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,6,12]}],"complexes":["neuronal nicotinic acetylcholine receptor (nAChR pentamer)"],"partners":["CHRNB4","CHRNA5","FOXA2"],"other_free_text":[]},"mechanistic_narrative":"CHRNA3 encodes the α3 subunit of neuronal nicotinic acetylcholine receptors (nAChRs), which is essential for fast cholinergic synaptic transmission in autonomic ganglia and contributes to central nervous system circuits underlying sensorimotor gating, locomotion, and alcohol-related behaviors. Mice lacking the α3 subunit exhibit megacystis, pupil dilation, growth failure, and perinatal lethality due to loss of ganglionic nicotinic transmission [PMID:11450844], and biallelic loss-of-function variants in humans cause familial panautonomic failure with neurogenic orthostatic hypotension, gastrointestinal dysmotility, and bladder dysfunction [PMID:33947782, PMID:38192228]. CHRNA3 transcription is regulated by a cis-acting enhancer containing rs2036527 that is bound by FOXA2 and physically loops to the CHRNA3 promoter, with additional allele-specific regulatory inputs from intergenic SNPs (rs8023462, rs6495309) that recruit GATA factors and modulate expression in a cell-type-dependent manner [PMID:40755048, PMID:23872218]. In the CNS, CHRNA3 variation modulates nicotine's effect on prepulse inhibition of startle [PMID:23604333], and zebrafish chrna3 knockout alters alcohol self-administration and tolerance through changes in cholinergic, glutamatergic, and GABAergic signaling [PMID:40992927]."},"prefetch_data":{"uniprot":{"accession":"P32297","full_name":"Neuronal acetylcholine receptor subunit alpha-3","aliases":[],"length_aa":505,"mass_kda":57.5,"function":"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (PubMed:31488329, PubMed:31708116). CHRNA3 forms heteropentameric neuronal acetylcholine receptors with CHRNB2 and CHRNB4, with CHRNA5, and CHRNB3 as accesory subunits (PubMed:20881005, PubMed:8663494). CHRNA3:CHRNB4 being predominant in neurons of the autonomic ganglia, it is known as ganglionic nicotinic receptor (PubMed:31488329). CHRNA3:CHRNB4 or CHRNA3:CHRNA5:CHRNB4 play also an important role in the habenulo-interpeduncular tract, modulating the mesolimbic dopamine system and affecting reward circuits and addiction (By similarity). Hypothalamic CHRNA3:CHRNB4 nAChR activation by nicotine leads to activation of POMC neurons and a decrease in food intake (By similarity). Also expressed in the urothelium where it modulates reflex bladder activity by increasing intracellular calcium through extracellular influx and basal ATP release (By similarity)","subcellular_location":"Synaptic cell membrane; Cell membrane; Endoplasmic reticulum; Golgi apparatus","url":"https://www.uniprot.org/uniprotkb/P32297/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHRNA3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CHRNA3","total_profiled":1310},"omim":[{"mim_id":"612052","title":"SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3","url":"https://www.omim.org/entry/612052"},{"mim_id":"610509","title":"RIC3 ACETYLCHOLINE RECEPTOR CHAPERONE; RIC3","url":"https://www.omim.org/entry/610509"},{"mim_id":"603204","title":"EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2","url":"https://www.omim.org/entry/603204"},{"mim_id":"600513","title":"EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1","url":"https://www.omim.org/entry/600513"},{"mim_id":"249210","title":"MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1; MMIHS1","url":"https://www.omim.org/entry/249210"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"},{"location":"Primary cilium tip","reliability":"Additional"},{"location":"Primary cilium transition zone","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"adrenal gland","ntpm":37.1},{"tissue":"lymphoid tissue","ntpm":61.2},{"tissue":"retina","ntpm":49.6}],"url":"https://www.proteinatlas.org/search/CHRNA3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P32297","domains":[{"cath_id":"2.70.170.10","chopping":"35-240","consensus_level":"high","plddt":94.3226,"start":35,"end":240},{"cath_id":"1.20.58.390","chopping":"245-357_479-503","consensus_level":"high","plddt":88.2435,"start":245,"end":503}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P32297","model_url":"https://alphafold.ebi.ac.uk/files/AF-P32297-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P32297-F1-predicted_aligned_error_v6.png","plddt_mean":81.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHRNA3","jax_strain_url":"https://www.jax.org/strain/search?query=CHRNA3"},"sequence":{"accession":"P32297","fasta_url":"https://rest.uniprot.org/uniprotkb/P32297.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P32297/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P32297"}},"corpus_meta":[{"pmid":"19706762","id":"PMC_19706762","title":"The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19706762","citation_count":218,"is_preprint":false},{"pmid":"21747048","id":"PMC_21747048","title":"Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.","date":"2011","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/21747048","citation_count":152,"is_preprint":false},{"pmid":"19429911","id":"PMC_19429911","title":"A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19429911","citation_count":121,"is_preprint":false},{"pmid":"22648373","id":"PMC_22648373","title":"Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.","date":"2012","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22648373","citation_count":115,"is_preprint":false},{"pmid":"21593077","id":"PMC_21593077","title":"Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index.","date":"2011","source":"International journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/21593077","citation_count":94,"is_preprint":false},{"pmid":"19628476","id":"PMC_19628476","title":"Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19628476","citation_count":91,"is_preprint":false},{"pmid":"27029810","id":"PMC_27029810","title":"Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27029810","citation_count":76,"is_preprint":false},{"pmid":"20393456","id":"PMC_20393456","title":"Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.","date":"2010","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20393456","citation_count":67,"is_preprint":false},{"pmid":"21690317","id":"PMC_21690317","title":"CHRNA3 rs1051730 genotype and short-term smoking cessation.","date":"2011","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/21690317","citation_count":62,"is_preprint":false},{"pmid":"21168125","id":"PMC_21168125","title":"TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21168125","citation_count":62,"is_preprint":false},{"pmid":"22956269","id":"PMC_22956269","title":"Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22956269","citation_count":58,"is_preprint":false},{"pmid":"22544838","id":"PMC_22544838","title":"From men to mice: CHRNA5/CHRNA3, smoking behavior and disease.","date":"2012","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/22544838","citation_count":54,"is_preprint":false},{"pmid":"20886544","id":"PMC_20886544","title":"Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20886544","citation_count":52,"is_preprint":false},{"pmid":"21623257","id":"PMC_21623257","title":"Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma.","date":"2011","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21623257","citation_count":52,"is_preprint":false},{"pmid":"19859904","id":"PMC_19859904","title":"Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19859904","citation_count":51,"is_preprint":false},{"pmid":"22241830","id":"PMC_22241830","title":"Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits.","date":"2012","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/22241830","citation_count":50,"is_preprint":false},{"pmid":"22356581","id":"PMC_22356581","title":"Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency.","date":"2012","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/22356581","citation_count":38,"is_preprint":false},{"pmid":"24057674","id":"PMC_24057674","title":"Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24057674","citation_count":36,"is_preprint":false},{"pmid":"22914670","id":"PMC_22914670","title":"Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.","date":"2012","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22914670","citation_count":32,"is_preprint":false},{"pmid":"23056235","id":"PMC_23056235","title":"Functional polymorphisms of CHRNA3 predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23056235","citation_count":32,"is_preprint":false},{"pmid":"24186853","id":"PMC_24186853","title":"Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking.","date":"2013","source":"Genetic epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/24186853","citation_count":29,"is_preprint":false},{"pmid":"9921897","id":"PMC_9921897","title":"The structures of the human neuronal nicotinic acetylcholine receptor beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3).","date":"1998","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9921897","citation_count":28,"is_preprint":false},{"pmid":"20631687","id":"PMC_20631687","title":"Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility.","date":"2010","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20631687","citation_count":25,"is_preprint":false},{"pmid":"27758088","id":"PMC_27758088","title":"The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.","date":"2016","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/27758088","citation_count":24,"is_preprint":false},{"pmid":"26689306","id":"PMC_26689306","title":"Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.","date":"2015","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26689306","citation_count":24,"is_preprint":false},{"pmid":"21559498","id":"PMC_21559498","title":"Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21559498","citation_count":24,"is_preprint":false},{"pmid":"22042234","id":"PMC_22042234","title":"Externalizing behaviors are associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 gene cluster.","date":"2011","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22042234","citation_count":22,"is_preprint":false},{"pmid":"23875064","id":"PMC_23875064","title":"Scrutiny of the CHRNA5-CHRNA3-CHRNB4 smoking behavior locus reveals a novel association with alcohol use in a Finnish population based study.","date":"2013","source":"International journal of molecular epidemiology and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23875064","citation_count":22,"is_preprint":false},{"pmid":"11450844","id":"PMC_11450844","title":"Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4.","date":"2001","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11450844","citation_count":22,"is_preprint":false},{"pmid":"25051068","id":"PMC_25051068","title":"Four SNPs in the CHRNA3/5 alpha-neuronal nicotinic acetylcholine receptor subunit locus are associated with COPD risk based on meta-analyses.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25051068","citation_count":21,"is_preprint":false},{"pmid":"23872218","id":"PMC_23872218","title":"Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors.","date":"2013","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23872218","citation_count":20,"is_preprint":false},{"pmid":"24065931","id":"PMC_24065931","title":"The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers.","date":"2013","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24065931","citation_count":20,"is_preprint":false},{"pmid":"21385908","id":"PMC_21385908","title":"Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.","date":"2011","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/21385908","citation_count":19,"is_preprint":false},{"pmid":"21810735","id":"PMC_21810735","title":"Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada.","date":"2011","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/21810735","citation_count":19,"is_preprint":false},{"pmid":"21858091","id":"PMC_21858091","title":"In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21858091","citation_count":19,"is_preprint":false},{"pmid":"29666375","id":"PMC_29666375","title":"Association and cis-mQTL analysis of variants in CHRNA3-A5, CHRNA7, CHRNB2, and CHRNB4 in relation to nicotine dependence in a Chinese Han population.","date":"2018","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29666375","citation_count":18,"is_preprint":false},{"pmid":"23397474","id":"PMC_23397474","title":"Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population.","date":"2012","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23397474","citation_count":17,"is_preprint":false},{"pmid":"21748402","id":"PMC_21748402","title":"A twin association study of nicotine dependence with markers in the CHRNA3 and CHRNA5 genes.","date":"2011","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21748402","citation_count":17,"is_preprint":false},{"pmid":"25214750","id":"PMC_25214750","title":"Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment.","date":"2013","source":"Journal of food and drug analysis","url":"https://pubmed.ncbi.nlm.nih.gov/25214750","citation_count":14,"is_preprint":false},{"pmid":"23604333","id":"PMC_23604333","title":"The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism.","date":"2013","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23604333","citation_count":14,"is_preprint":false},{"pmid":"24686516","id":"PMC_24686516","title":"CHRNA3 polymorphism modifies lung adenocarcinoma risk in the Chinese Han population.","date":"2014","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24686516","citation_count":14,"is_preprint":false},{"pmid":"10923651","id":"PMC_10923651","title":"Refined mapping of CHRNA3/A5/B4 gene cluster and its implications in ADNFLE.","date":"2000","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/10923651","citation_count":11,"is_preprint":false},{"pmid":"23729684","id":"PMC_23729684","title":"Smoking status, snus use, and variation at the CHRNA5-CHRNA3-CHRNB4 locus in relation to obesity: the GLACIER study.","date":"2013","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/23729684","citation_count":11,"is_preprint":false},{"pmid":"24588897","id":"PMC_24588897","title":"CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women.","date":"2014","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/24588897","citation_count":11,"is_preprint":false},{"pmid":"33947782","id":"PMC_33947782","title":"Familial Autonomic Ganglionopathy Caused by Rare CHRNA3 Genetic Variants.","date":"2021","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33947782","citation_count":10,"is_preprint":false},{"pmid":"28474623","id":"PMC_28474623","title":"IREB2, CHRNA5, CHRNA3, FAM13A & hedgehog interacting protein genes polymorphisms & risk of chronic obstructive pulmonary disease in Tatar population from Russia.","date":"2016","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/28474623","citation_count":10,"is_preprint":false},{"pmid":"23255854","id":"PMC_23255854","title":"A functional polymorphism in the CHRNA3 gene and risk of chronic obstructive pulmonary disease in a Korean population.","date":"2012","source":"Journal of Korean medical science","url":"https://pubmed.ncbi.nlm.nih.gov/23255854","citation_count":10,"is_preprint":false},{"pmid":"34707353","id":"PMC_34707353","title":"The Cumulative Effect of Gene-Gene Interactions Between GSTM1, CHRNA3, CHRNA5 and SOD3 Gene Polymorphisms Combined with Smoking on COPD Risk.","date":"2021","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/34707353","citation_count":10,"is_preprint":false},{"pmid":"25656608","id":"PMC_25656608","title":"CHRNA3 genetic polymorphism and the risk of lung cancer in the Chinese Han smoking population.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25656608","citation_count":9,"is_preprint":false},{"pmid":"25891420","id":"PMC_25891420","title":"Exon sequencing identifies a novel CHRNA3-CHRNA5-CHRNB4 variant that increases the risk for chronic obstructive pulmonary disease.","date":"2015","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/25891420","citation_count":9,"is_preprint":false},{"pmid":"21511889","id":"PMC_21511889","title":"Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking.","date":"2011","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/21511889","citation_count":9,"is_preprint":false},{"pmid":"23029550","id":"PMC_23029550","title":"Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029550","citation_count":9,"is_preprint":false},{"pmid":"29416783","id":"PMC_29416783","title":"Study on polymorphisms in CHRNA5/CHRNA3/CHRNB4 gene cluster and the associated with the risk of non-small cell lung cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29416783","citation_count":9,"is_preprint":false},{"pmid":"25399010","id":"PMC_25399010","title":"Association between polymorphisms in CHRNA3 and PHACTR2 gene and environment and NSCLC risk in Chinese population.","date":"2014","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/25399010","citation_count":8,"is_preprint":false},{"pmid":"26942719","id":"PMC_26942719","title":"Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26942719","citation_count":8,"is_preprint":false},{"pmid":"36078193","id":"PMC_36078193","title":"Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine.","date":"2022","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/36078193","citation_count":7,"is_preprint":false},{"pmid":"25288178","id":"PMC_25288178","title":"The association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25288178","citation_count":7,"is_preprint":false},{"pmid":"19733931","id":"PMC_19733931","title":"Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.","date":"2009","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/19733931","citation_count":7,"is_preprint":false},{"pmid":"31362771","id":"PMC_31362771","title":"CHRNA5/CHRNA3 gene cluster is a risk factor for lumbar disc herniation: a case-control study.","date":"2019","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/31362771","citation_count":7,"is_preprint":false},{"pmid":"26002565","id":"PMC_26002565","title":"Identification of Deleterious SNPs and Their Effects on Structural Level in CHRNA3 Gene.","date":"2015","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26002565","citation_count":6,"is_preprint":false},{"pmid":"23023782","id":"PMC_23023782","title":"Correlation between polymorphisms of nicotine acetylcholine acceptor subunit CHRNA3 and lung cancer susceptibility.","date":"2012","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/23023782","citation_count":6,"is_preprint":false},{"pmid":"24337855","id":"PMC_24337855","title":"Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: a case-control study.","date":"2013","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/24337855","citation_count":6,"is_preprint":false},{"pmid":"23207642","id":"PMC_23207642","title":"CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea.","date":"2012","source":"Respiration; international review of thoracic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23207642","citation_count":6,"is_preprint":false},{"pmid":"25806352","id":"PMC_25806352","title":"CHRNA3 rs1051730 polymorphism and lung cancer susceptibility in Asian population: a meta-analysis.","date":"2015","source":"Translational lung cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25806352","citation_count":5,"is_preprint":false},{"pmid":"21228559","id":"PMC_21228559","title":"An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease.","date":"2011","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21228559","citation_count":5,"is_preprint":false},{"pmid":"30882151","id":"PMC_30882151","title":"Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.","date":"2020","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/30882151","citation_count":5,"is_preprint":false},{"pmid":"27127891","id":"PMC_27127891","title":"Association Between CHRNA3 and CHRNA5 Nicotine Receptor Subunit Gene Variants and Nicotine Dependence in an Isolated Populationof Kashubians in Poland.","date":"2016","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/27127891","citation_count":5,"is_preprint":false},{"pmid":"26751916","id":"PMC_26751916","title":"CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.","date":"2016","source":"COPD","url":"https://pubmed.ncbi.nlm.nih.gov/26751916","citation_count":5,"is_preprint":false},{"pmid":"25845234","id":"PMC_25845234","title":"[Association of the nicotine and cigarette smoke toxicants metabolic (CHRNA3/5, CYP2A6, NQO1) and DNA repair genes (XRCC1, XRCC3, XPC, XPA) with chronic obstructive pulmonary disease].","date":"2014","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/25845234","citation_count":5,"is_preprint":false},{"pmid":"38862938","id":"PMC_38862938","title":"Investigating CHRNA5, CHRNA3, and CHRNB4 variants in the genetic landscape of substance use disorder in Jordan.","date":"2024","source":"BMC psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/38862938","citation_count":4,"is_preprint":false},{"pmid":"28240528","id":"PMC_28240528","title":"Novel Mutations of the CHRNA3 Gene in Non-Small Cell Lung Cancer in an Iranian Population.","date":"2017","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/28240528","citation_count":3,"is_preprint":false},{"pmid":"39686588","id":"PMC_39686588","title":"Novel Transgenic Zebrafish Lines to Study the CHRNA3-B4-A5 Gene Cluster.","date":"2025","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39686588","citation_count":3,"is_preprint":false},{"pmid":"35865987","id":"PMC_35865987","title":"CHRNA5 rs16969968 and CHRNA3 rs578776 polymorphisms are associated with multiple nicotine dependence phenotypes in Bangladeshi smokers.","date":"2022","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/35865987","citation_count":3,"is_preprint":false},{"pmid":"29879020","id":"PMC_29879020","title":"Association analysis of CHRNA3 polymorphisms with schizophrenia in a Chinese Han population: A case-control study.","date":"2018","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29879020","citation_count":3,"is_preprint":false},{"pmid":"25874685","id":"PMC_25874685","title":"CHRNA3 rs6495308 genotype as an effect modifier of the association between daily cigarette consumption and hypertension in Chinese male smokers.","date":"2015","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/25874685","citation_count":2,"is_preprint":false},{"pmid":"34522797","id":"PMC_34522797","title":"The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population.","date":"2021","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/34522797","citation_count":2,"is_preprint":false},{"pmid":"40072291","id":"PMC_40072291","title":"Investigating the role of eight SNPs in CHRNA3 for COPD susceptibility in the Chinese elderly population.","date":"2025","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40072291","citation_count":1,"is_preprint":false},{"pmid":"38192228","id":"PMC_38192228","title":"Novel CHRNA3 variants identified in a patient with bladder dysfunction, dysautonomia, and gastrointestinal dysmotility.","date":"2024","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/38192228","citation_count":1,"is_preprint":false},{"pmid":"40992927","id":"PMC_40992927","title":"chrna3 Modulates Alcohol Response.","date":"2025","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40992927","citation_count":1,"is_preprint":false},{"pmid":"40755048","id":"PMC_40755048","title":"Identification of rs2036527 as a cis-regulatory variant for CHRNA3 and CHRNA5 by allele-specific expression and implications for nicotine dependence and lung cancer.","date":"2025","source":"The American journal on addictions","url":"https://pubmed.ncbi.nlm.nih.gov/40755048","citation_count":1,"is_preprint":false},{"pmid":"31588985","id":"PMC_31588985","title":"[Analysis of polymorphism rs1051730 of CHRNA3 in patients with dual pathology in a Mexican population].","date":"2019","source":"Revista de neurologia","url":"https://pubmed.ncbi.nlm.nih.gov/31588985","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.22.607435","title":"<i>chrna3</i> modulates alcohol response","date":"2024-08-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.22.607435","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.01.621506","title":"Molecular and Functional Asymmetry in Cckar-expressing Vagal Sensory Neurons","date":"2024-11-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.01.621506","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45830,"output_tokens":3393,"usd":0.094192},"stage2":{"model":"claude-opus-4-6","input_tokens":6781,"output_tokens":2504,"usd":0.144758},"total_usd":0.23895,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"The CHRNA3 gene (encoding the neuronal nicotinic acetylcholine receptor α3 subunit) was structurally characterized: its genomic organization was determined and it was mapped to the chromosome 15q24 gene cluster together with CHRNB4 and CHRNA5, providing the structural basis for mutational analyses.\",\n      \"method\": \"Genomic cloning and structural characterization\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct structural/genomic characterization; single lab, single method\",\n      \"pmids\": [\"9921897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mice lacking the α3 subunit (CHRNA3 ortholog) show severe autonomic phenotypes including megacystis, failure of bladder strips to contract in response to nicotine, widely dilated ocular pupils, growth failure, and perinatal mortality, establishing CHRNA3 as essential for nicotinic fast synaptic transmission in autonomic ganglia.\",\n      \"method\": \"Knockout mouse model with pharmacological and functional assays (bladder contraction assay)\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular/organ phenotype including in vitro pharmacological assay; consistent with human disease data\",\n      \"pmids\": [\"11450844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Refined genetic mapping placed the CHRNA3/A5/B4 cluster in a 0.6 cM interval between STRs D15S1027 and D15S1005 on chromosome 15q24, and segregation analysis excluded this cluster from the ADNFLE-linked 15q24 region.\",\n      \"method\": \"Genetic mapping via segregation analysis of polymorphisms in ADNFLE families\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genetic mapping with family segregation data; single lab\",\n      \"pmids\": [\"10923651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In vitro luciferase reporter assays showed that CHRNA3 promoter haplotypes produced equivalent luciferase expression in BE(2)-C neuronal cells, while CHRNA5 promoter variants altered expression; allelic expression imbalance (AEI) analysis in post-mortem brain tissue heterozygous at CHRNA3 rs1051730 showed mostly equivalent allelic expression, suggesting CHRNA3 promoter haplotypes do not strongly drive differential mRNA output.\",\n      \"method\": \"Luciferase reporter assay (in vitro), allelic expression imbalance analysis in post-mortem brain tissue\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional assay plus ex vivo tissue analysis; single lab with two orthogonal methods\",\n      \"pmids\": [\"21858091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In vitro luciferase assays showed that the CHRNA3/B4 intergenic SNPs rs8023462 and rs6495309 influence gene expression in an allele-specific, cell-type-dependent manner; EMSA demonstrated that nuclear proteins bind rs8023462 and rs6495309 alleles differentially, and GATA transcription factors bind rs8023462 only when the minor/risk allele is present.\",\n      \"method\": \"Luciferase reporter assay, electrophoretic mobility shift assay (EMSA), transcription factor binding analysis\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple orthogonal methods (luciferase + EMSA + specific TF identification)\",\n      \"pmids\": [\"23872218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Integration of GTEx RNA expression data showed that the CHRNA5 enhancer haplotype tagged by rs880395 increases CHRNA3 mRNA expression (in addition to CHRNA5), suggesting DNA looping from a shared enhancer to multiple promoters; in nucleus accumbens and putamen specifically, CHRNA3 expression associates with a distinct haplotype tagged by rs1948 in the CHRNB4 3'UTR, indicating brain-region-specific regulatory mechanisms.\",\n      \"method\": \"eQTL analysis using GTEx data, chromatin looping inference, linkage disequilibrium analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — regulatory inference from large-scale RNA data without direct chromatin confirmation; but multiple datasets used\",\n      \"pmids\": [\"27758088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss-of-function variants in CHRNA3 (compound heterozygous frameshift c.907_908delCT/missense p.D230N, or homozygous frameshift) cause familial autonomic ganglionopathy with diffuse panautonomic failure (severe neurogenic orthostatic hypotension, non-reactive miotic pupils, constipation, low norepinephrine), establishing CHRNA3 as essential for fast ganglionic synaptic transmission in the human autonomic nervous system. Structural modeling predicted the p.D230N variant destabilizes the nAChR pentameric complex at the subunit interface.\",\n      \"method\": \"Whole exome sequencing, genetic co-segregation, structural modeling (PolyPhen2/SIFT/protein modeling)\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function variants with defined human disease phenotype replicated across two unrelated families; structural modeling provides mechanistic support\",\n      \"pmids\": [\"33947782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Novel compound heterozygous CHRNA3 variants were identified in a patient with neurogenic bladder, vesicoureteral reflux, mydriasis, and gastrointestinal dysmotility, extending the phenotypic spectrum of CHRNA3 loss of function to include CAKUT features consistent with disrupted autonomic ganglionic neurotransmission.\",\n      \"method\": \"Clinical genetic sequencing, phenotypic characterization\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single case report with genetic variants; mechanistic inference based on known CHRNA3 function\",\n      \"pmids\": [\"38192228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In zebrafish, chrna3 knockout blunted the biphasic (attraction-to-aversion) alcohol self-administration response and increased alcohol tolerance; transcriptomic analysis of mutant brains showed changes in glutamatergic, GABAergic, and cholinergic signaling, establishing that chrna3 modulates alcohol response through its role in cholinergic signaling in the CNS.\",\n      \"method\": \"Zebrafish chrna3 knockout, two-choice self-administration behavioral assay, transcriptomic analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral phenotype plus transcriptomic mechanism; single lab, ortholog model\",\n      \"pmids\": [\"40992927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Chromosome conformation capture (3C) identified that rs2036527 lies in an enhancer region that physically interacts with the CHRNA3 promoter (and also CHRNA5 promoter); luciferase assay confirmed rs2036527 alters enhancer activity; ChIP identified FOXA2 as a transcription factor that interacts with the rs2036527-containing enhancer. Allele-specific expression showed the C allele at rs1051730 (in strong LD with rs2036527) is overexpressed in lung tissue, establishing rs2036527 as the functional cis-regulatory variant for CHRNA3 expression.\",\n      \"method\": \"3C (chromosome conformation capture), luciferase assay, ChIP, allele-specific expression analysis, eQTL analysis\",\n      \"journal\": \"The American journal on addictions\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (3C + luciferase + ChIP + allele-specific expression) in single study identifying functional regulatory variant and transcription factor\",\n      \"pmids\": [\"40755048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Luciferase assays in lung-cancer-derived cell lines showed that nicotine and other tobacco chemicals have diverse effects on luciferase activity driven by the CHRNA3 promoter rs6495309C or T alleles, indicating that the rs6495309T>C polymorphism in the CHRNA3 promoter affects transcriptional activity in a ligand- and allele-dependent manner.\",\n      \"method\": \"Luciferase reporter assay with nicotine and tobacco chemical treatment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay demonstrating allele-dependent promoter activity; single lab, single method\",\n      \"pmids\": [\"23056235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Transgenic zebrafish expressing fluorescent reporters under chrna3 regulatory sequences showed that chrna3 is expressed in both the peripheral and central nervous systems, including enteric nervous system, lateral line efferent inhibitory neurons, and spinal cord motor neurons and interneurons (including dmrt3a-expressing interneurons), establishing a basis for its role in the locomotor network and autonomic function.\",\n      \"method\": \"Transgenic reporter zebrafish, fluorescence imaging, co-expression analysis with cell-type markers\",\n      \"journal\": \"Developmental neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo localization with functional cell-type context; ortholog in zebrafish\",\n      \"pmids\": [\"39686588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CHRNA3 rs1051730 polymorphism was associated with reduced prepulse inhibition (PPI) of the acoustic startle response in two independent samples (healthy volunteers and schizophrenia patients), indicating that CHRNA3 genetic variation influences sensorimotor gating, a function mediated by nicotinic acetylcholine receptor signaling.\",\n      \"method\": \"Human genetic association with electrophysiological endophenotype (PPI), replicated in two independent cohorts\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic association with functional electrophysiological readout; replicated across two independent samples\",\n      \"pmids\": [\"20393456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In healthy nonsmoking volunteers in a placebo-controlled crossover study, nicotine enhanced PPI only in CHRNA3 rs1051730 TT homozygotes and tended to worsen PPI in TC/CC carriers, demonstrating that CHRNA3 genotype modulates the pharmacological effect of nicotine on sensorimotor gating.\",\n      \"method\": \"Double-blind placebo-controlled crossover study with PPI measurement and CHRNA3 genotyping; cotinine plasma levels measured\",\n      \"journal\": \"Psychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — controlled pharmacological challenge with functional readout and genotype stratification; single lab\",\n      \"pmids\": [\"23604333\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHRNA3 encodes the α3 subunit of the neuronal nicotinic acetylcholine receptor (nAChR), which is essential for fast cholinergic synaptic transmission in autonomic ganglia (established by mouse knockout and human loss-of-function variants causing panautonomic failure); its expression is regulated by a cis-acting enhancer containing rs2036527 that is bound by FOXA2 and loops to the CHRNA3 (and CHRNA5) promoter, with allele-specific effects on transcription; intergenic SNPs (rs8023462, rs6495309) in the CHRNA3/B4 region also modulate gene expression through allele-specific nuclear protein binding including GATA transcription factors; CHRNA3 variation influences sensorimotor gating (PPI) through nicotinic receptor-mediated mechanisms, and its zebrafish ortholog regulates alcohol tolerance via cholinergic, glutamatergic, and GABAergic signaling in the brain.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CHRNA3 encodes the α3 subunit of neuronal nicotinic acetylcholine receptors (nAChRs), which is essential for fast cholinergic synaptic transmission in autonomic ganglia and contributes to central nervous system circuits underlying sensorimotor gating, locomotion, and alcohol-related behaviors. Mice lacking the α3 subunit exhibit megacystis, pupil dilation, growth failure, and perinatal lethality due to loss of ganglionic nicotinic transmission [PMID:11450844], and biallelic loss-of-function variants in humans cause familial panautonomic failure with neurogenic orthostatic hypotension, gastrointestinal dysmotility, and bladder dysfunction [PMID:33947782, PMID:38192228]. CHRNA3 transcription is regulated by a cis-acting enhancer containing rs2036527 that is bound by FOXA2 and physically loops to the CHRNA3 promoter, with additional allele-specific regulatory inputs from intergenic SNPs (rs8023462, rs6495309) that recruit GATA factors and modulate expression in a cell-type-dependent manner [PMID:40755048, PMID:23872218]. In the CNS, CHRNA3 variation modulates nicotine's effect on prepulse inhibition of startle [PMID:23604333], and zebrafish chrna3 knockout alters alcohol self-administration and tolerance through changes in cholinergic, glutamatergic, and GABAergic signaling [PMID:40992927].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Defining the genomic architecture of the CHRNA3/A5/B4 cluster on 15q24 provided the structural framework needed to pursue mutational and regulatory analyses of the α3 subunit gene.\",\n      \"evidence\": \"Genomic cloning and structural characterization of CHRNA3 gene organization and chromosomal mapping\",\n      \"pmids\": [\"9921897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional data on receptor assembly or stoichiometry\", \"Promoter regulatory elements not yet tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Knockout of the mouse α3 subunit established that CHRNA3 is required for fast nicotinic synaptic transmission in autonomic ganglia, explaining the severe autonomic phenotype (megacystis, pupil dilation, perinatal death).\",\n      \"evidence\": \"Chrna3 knockout mice with bladder contraction pharmacological assays showing absent nicotine response\",\n      \"pmids\": [\"11450844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human disease causation not yet demonstrated\", \"Contribution to CNS function not addressed\", \"Whether other nAChR subunits can partially compensate in specific ganglia unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"CHRNA3 rs1051730 was linked to reduced prepulse inhibition in two independent human cohorts, revealing a CNS function for CHRNA3 in sensorimotor gating beyond its autonomic role.\",\n      \"evidence\": \"Genetic association of rs1051730 with PPI of acoustic startle in healthy volunteers and schizophrenia patients\",\n      \"pmids\": [\"20393456\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Association does not prove causality at CHRNA3 vs linked variants\", \"Neural circuit mediating the PPI effect not identified\", \"No pharmacological confirmation yet\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Promoter haplotype testing showed CHRNA3 promoter variants themselves do not strongly drive allelic expression imbalance in brain, redirecting attention to distal regulatory elements.\",\n      \"evidence\": \"Luciferase reporter assays in BE(2)-C cells and allelic expression imbalance analysis in post-mortem brain tissue\",\n      \"pmids\": [\"21858091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Distal enhancer elements not yet tested\", \"Tissue-specific regulation beyond brain not examined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The rs6495309 polymorphism in the CHRNA3 promoter region was shown to alter transcriptional activity in response to nicotine and tobacco chemicals in an allele-dependent manner, linking environmental exposure to genotype-specific gene regulation.\",\n      \"evidence\": \"Luciferase reporter assays with nicotine/tobacco chemical treatments in lung cancer cell lines\",\n      \"pmids\": [\"23056235\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of ligand-dependent promoter modulation not confirmed\", \"Transcription factors mediating the response not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two advances refined CHRNA3 regulation and CNS pharmacology: intergenic SNPs rs8023462/rs6495309 were shown to recruit allele-specific nuclear proteins including GATA factors to regulate CHRNA3/B4 expression, and a pharmacological challenge study demonstrated that CHRNA3 genotype determines whether nicotine enhances or worsens sensorimotor gating.\",\n      \"evidence\": \"EMSA and luciferase assays identifying GATA binding at rs8023462; double-blind placebo-controlled nicotine crossover study with PPI and rs1051730 genotyping\",\n      \"pmids\": [\"23872218\", \"23604333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GATA factor identity not specified beyond family level\", \"Whether PPI genotype effect is mediated by CHRNA3 expression level or receptor function unknown\", \"ChIP confirmation of GATA binding at endogenous locus not performed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"GTEx eQTL analysis revealed that a shared enhancer haplotype (tagged by rs880395) increases both CHRNA3 and CHRNA5 expression, while brain-region-specific regulation of CHRNA3 maps to a distinct CHRNB4 3'UTR haplotype, indicating multi-layered cis-regulatory control.\",\n      \"evidence\": \"eQTL analysis across GTEx tissues with linkage disequilibrium and chromatin looping inference\",\n      \"pmids\": [\"27758088\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physical chromatin contact not directly demonstrated (inferred from eQTL data)\", \"Mechanism of region-specific regulation not elucidated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of biallelic CHRNA3 loss-of-function variants in two unrelated families with panautonomic failure proved that CHRNA3 is essential for human autonomic ganglionic transmission, translating the mouse knockout phenotype to a defined Mendelian disease.\",\n      \"evidence\": \"Whole exome sequencing, co-segregation in two families, structural modeling of p.D230N at pentameric subunit interface\",\n      \"pmids\": [\"33947782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No electrophysiological recording from patient ganglia\", \"Receptor assembly and trafficking effects of mutations not tested in vitro\", \"Potential CNS manifestations not systematically assessed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Three studies broadened the functional portrait: zebrafish chrna3 knockout established a role in alcohol tolerance via cholinergic/glutamatergic/GABAergic signaling; transgenic reporters mapped chrna3 expression to enteric, lateral line, and spinal motor/interneuron populations; and chromosome conformation capture identified rs2036527 as a functional cis-regulatory variant in a FOXA2-bound enhancer that physically contacts the CHRNA3 promoter.\",\n      \"evidence\": \"Zebrafish KO with behavioral and transcriptomic analysis; transgenic fluorescent reporters with cell-type markers; 3C, ChIP, luciferase, and allele-specific expression in human lung tissue\",\n      \"pmids\": [\"40992927\", \"39686588\", \"40755048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXA2-enhancer mechanism operates in neuronal tissues beyond lung not tested\", \"Circuit-level mechanism by which chrna3 loss alters alcohol response unknown\", \"Human in vivo confirmation of enhancer-promoter loop pending\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for α3 subunit incorporation into specific pentameric receptor subtypes, the identity of CHRNA3-containing receptor complexes in different CNS circuits, and whether enhancer-mediated regulation by FOXA2 and GATA factors operates in autonomic ganglia where CHRNA3 function is most critical.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No cryo-EM or crystallographic structure of α3-containing pentamers\", \"Subunit stoichiometry preferences (α3β4 vs α3β2 vs mixed) in native tissue not resolved\", \"Tissue-specific enhancer activity in autonomic neurons not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 6, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 6, 8, 12, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 6, 12]}\n    ],\n    \"complexes\": [\n      \"neuronal nicotinic acetylcholine receptor (nAChR pentamer)\"\n    ],\n    \"partners\": [\n      \"CHRNB4\",\n      \"CHRNA5\",\n      \"FOXA2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}